US 11207339
Targeted cancer therapy
granted A61KA61K31/7088A61K35/761
Quick answer
US patent 11207339 (Targeted cancer therapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/7088, A61K35/761, A61K35/763, A61K35/765